Clinical Trials
5 trialsNCT04857619 2024-07-11
Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer
AstraZeneca
Completed
NCT02101385 2023-09-28
Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
Hoosier Cancer Research Network
Phase 2 Completed
NCT02733601 2023-04-03
BreCaReAl
AstraZeneca
Completed
NCT04807595 2023-03-06
Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status
AstraZeneca
Completed
NCT00445731 2014-09-08
A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant
University of Minnesota
Phase NA Completed